Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
21.16
-3.44 (-13.98%)
At close: Dec 26, 2025, 4:00 PM EST
21.12
-0.04 (-0.19%)
After-hours: Dec 26, 2025, 7:58 PM EST
RGC Market Cap
RGC has a market cap or net worth of $10.46 billion as of December 26, 2025. Its market cap has increased by 14,466.68% in one year.
Market Cap
10.46B
Enterprise Value
10.46B
1-Year Change
14,466.68%
Ranking
Category
Stock Price
$21.16
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $10.46B, an increase of 8,612.23%. That is a compound annual growth rate of 172.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 10.46B | 16,176.92% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |